Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT04504279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescent and Adult Subjects (Ages 2 Years and Older) With Mild to Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the potential improvement in atopic dermatitis signs and symptoms following the application of FB-401 in patients 2 years or older with mild to moderate atopic dermatitis. FB-401 will be applied topically for 16 weeks and progress will be assessed by assessment of the skin and patient reports.
Study identification
- NCT ID
- NCT04504279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 154 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2020
- Primary completion
- Jul 13, 2021
- Completion
- Aug 18, 2021
- Last update posted
- Sep 15, 2021
2020 – 2021
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Multi-Specialty Research Associates, Inc. | Lake City | Florida | 32055 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| DS Research | Clarksville | Indiana | 47129 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Lawrence J. Green MD LLC | Rockville | Maryland | 20850 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| Midwest Children's Health Research Institute | Lincoln | Nebraska | 68516 | — |
| Dermatology Consulting Services, PLLC | High Point | North Carolina | 27262 | — |
| Cyn3rgy Research | Gresham | Oregon | 97030 | — |
| KGL Skin Study Center LLC | Newtown Square | Pennsylvania | 19073 | — |
| Bellaire Dermatology Associates | Bellaire | Texas | 77401 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04504279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2021 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04504279 live on ClinicalTrials.gov.